Back to Search
Start Over
Corrigendum to "A systematic review of higher-risk myelodysplastic syndromes clinical trials to determine the benchmark of azacitidine and explore alternative endpoints for overall survival" [Leukemia Res. 104 March (2021)].
- Source :
-
Leukemia research [Leuk Res] 2021 Jun; Vol. 105, pp. 106581. Date of Electronic Publication: 2021 Apr 23. - Publication Year :
- 2021
Details
- Language :
- English
- ISSN :
- 1873-5835
- Volume :
- 105
- Database :
- MEDLINE
- Journal :
- Leukemia research
- Accession number :
- 33896620
- Full Text :
- https://doi.org/10.1016/j.leukres.2021.106581